21317862

Source:http://linkedlifedata.com/resource/pubmed/id/21317862

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019829, umls-concept:C1098262
pubmed:issue	10
pubmed:dateCreated	2011-2-14
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101167661
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/galiximab
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1543-0790
pubmed:author	pubmed-author:SmithSonali MSM
pubmed:issnType	Print
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	669-70
pubmed:meshHeading	pubmed-meshheading:21317862-Antibodies, Monoclonal, pubmed-meshheading:21317862-Antineoplastic Agents, pubmed-meshheading:21317862-Clinical Trials, Phase II as Topic, pubmed-meshheading:21317862-Hodgkin Disease, pubmed-meshheading:21317862-Humans, pubmed-meshheading:21317862-Neoplasm Recurrence, Local
pubmed:year	2010
pubmed:articleTitle	Galiximab in relapsed hodgkin lymphoma.
pubmed:affiliation	Section of Hematology/Oncology, Lymphoma Program, The University of Chicago Medical Center, Chicago, IL 60637, USA.
pubmed:publicationType	Interview